↓ Skip to main content

Febuxostat for treating chronic gout

Overview of attention for article published in Cochrane database of systematic reviews, November 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

blogs
1 blog
twitter
11 tweeters

Citations

dimensions_citation
40 Dimensions

Readers on

mendeley
78 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Febuxostat for treating chronic gout
Published in
Cochrane database of systematic reviews, November 2012
DOI 10.1002/14651858.cd008653.pub2
Pubmed ID
Authors

Jean H Tayar, Maria Angeles Lopez-Olivo, Maria E Suarez-Almazor

Abstract

Gout is the most common inflammatory arthritis in men over 40 years and has an increasing prevalence among postmenopausal women. Lowering serum uric acid levels remains one of the primary goals in the treatment of chronic gout. In clinical trials, febuxostat has been shown to be effective in lowering serum uric acid levels to < 6.0 mg/dL.

Twitter Demographics

The data shown below were collected from the profiles of 11 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 78 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 3%
United Kingdom 1 1%
Italy 1 1%
Denmark 1 1%
India 1 1%
Unknown 72 92%

Demographic breakdown

Readers by professional status Count As %
Student > Master 17 22%
Student > Bachelor 16 21%
Researcher 11 14%
Unspecified 11 14%
Student > Postgraduate 9 12%
Other 14 18%
Readers by discipline Count As %
Medicine and Dentistry 38 49%
Unspecified 14 18%
Nursing and Health Professions 6 8%
Pharmacology, Toxicology and Pharmaceutical Science 5 6%
Social Sciences 5 6%
Other 10 13%

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 February 2019.
All research outputs
#1,120,232
of 12,706,057 outputs
Outputs from Cochrane database of systematic reviews
#3,556
of 10,402 outputs
Outputs of similar age
#23,267
of 252,512 outputs
Outputs of similar age from Cochrane database of systematic reviews
#208
of 517 outputs
Altmetric has tracked 12,706,057 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,402 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.3. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 252,512 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 517 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.